PF3D7_1418300

PF3D7_1418300 encodes Plasmodium falciparum calmodulin, a single-copy, single-intron Ca2+-binding regulatory protein on chromosome 14 that links intracellular Ca2+ signals to erythrocyte invasion and the intraerythrocytic cycle (PMID:1852174, PMID:18165240). Its expression is cell cycle-linked, low in rings and peaking in late trophozoites/schizonts through combined control of transcription and mRNA stability (PMID:8720124, PMID:15850701), and the protein localizes diffusely in the cytoplasm of mature parasites while concentrating at the apical end of merozoites, consistent with a role in invasion (PMID:3313391, PMID:3127214). Mechanistically, PfCaM acts as a Ca2+-dependent activator of downstream effectors: it directly binds and activates PfPKB via a calmodulin-binding domain in the kinase's N-terminus, and this activated PfPKB engages the actin-myosin motor and phosphorylates the glideosome component PfGAP45, coupling Ca2+ signaling to motility and invasion (PMID:16809343, PMID:18165240); it also stimulates calcineurin/PP2B phosphatase activity (PMID:10340482) and physically interacts with the ring-stage phosphatase PP7 (PMID:39387582). Beyond effector activation, PfCaM participates in intracellular Ca2+ homeostasis and calcium-dependent proteolysis, since its overexpression raises cytosolic Ca2+ responses and proteolytic activity (PMID:29913151, PMID:26689736). Structurally, Ca2+-saturated PfCaM binds targets through multiple non-classical modes at its hydrophobic pockets and is more conformationally stable than human calmodulin owing to a more stable C-terminal domain, while retaining similar target activation and inhibitor binding (PMID:32821880, PMID:36906144).

1. 1987 Medium

   Establishing where calmodulin resides and whether it matters for the parasite life cycle was the first step; localization to the merozoite apical pole and pharmacological blockade of invasion tied it to erythrocyte entry.

   Evidence radioimmunoassay and immunoelectron microscopy plus calmodulin-antagonist growth/invasion assays in P. falciparum

   PMID:3127214 PMID:3313391

   Open questions at the time

   • Antagonists are not calmodulin-specific, so invasion inhibition may reflect off-target effects
   • No molecular effector identified at this stage
2. 1991 High

   Defining the gene as a single-copy, single-intron locus 89% identical to mammalian calmodulin fixed its identity and ruled out a role in chloroquine resistance.

   Evidence Southern blotting, sequencing, and primer extension; comparison across chloroquine-resistant and -sensitive isolates in P. falciparum

   PMID:1852174 PMID:1915742

   Open questions at the time

   • Sequence identity to mammalian CaM does not establish parasite-specific function
   • Resistance analysis limited to the isolates tested
3. 1995 Medium

   Whether calmodulin was a constitutive housekeeping product or a regulated one was resolved by showing cell cycle-linked expression controlled at transcription and mRNA-stability levels.

   Evidence Northern/Western blotting and pulse-chase mRNA stability assays in P. falciparum

   PMID:8720124

   Open questions at the time

   • Regulatory factors driving the stage-specificity not identified
   • Link between expression timing and function not directly tested
4. 1999 Medium

   The first defined downstream effector was established by reconstituting calmodulin/Ca2+ stimulation of parasite calcineurin, showing PfCaM functions as a canonical phosphatase activator.

   Evidence purification of the PP2B-like phosphatase from cytosolic extracts and activity assays with calmodulin and Ca2+ in P. falciparum

   PMID:10340482

   Open questions at the time

   • In vivo relevance of calcineurin activation not demonstrated
   • Physiological substrates of the calcineurin cascade unresolved
5. 2005 Medium

   The cis-elements driving stage-specific calmodulin transcription were mapped, defining a promoter dependent on poly(dA)poly(dT) tracts bound by nuclear factors.

   Evidence transcription start site mapping, EMSA, and CAT reporter deletion analysis of the pfcam promoter in P. falciparum

   PMID:15850701

   Open questions at the time

   • Identity of the nuclear binding factors not determined
   • Mechanism connecting promoter elements to cell cycle timing unresolved
6. 2007 Medium

   A direct signaling route to invasion was built by showing PfCaM activates PfPKB via an N-terminal calmodulin-binding domain and that activated PfPKB phosphorylates the glideosome component PfGAP45.

   Evidence Co-IP, calmodulin-binding domain mapping, in vitro kinase assays with PfGAP45 substrate, and invasion assays in P. falciparum

   PMID:16809343 PMID:18165240

   Open questions at the time

   • Direct genetic ablation of the CaM-PfPKB interaction in vivo not performed
   • Contribution relative to other kinases in the motor complex unquantified
7. 2018 Medium

   Beyond effector activation, PfCaM was implicated in Ca2+ homeostasis and proteolysis by showing overexpression amplifies cytosolic Ca2+ responses and calcium-dependent protease activity.

   Evidence HA-knockin overexpression, live-cell Ca2+ imaging, and fluorometric protease assays in P. falciparum

   PMID:26689736 PMID:29913151

   Open questions at the time

   • Overexpression phenotype may not reflect endogenous stoichiometry
   • The specific proteases affected are not identified
8. 2020 Medium

   Comparing PfCaM biophysically to human CaM addressed its drug-target potential, revealing greater conformational stability from a more stable C-terminal domain despite similar target activation and inhibitor affinities.

   Evidence recombinant protein, thermal stability assays, fluorescence binding, and enzyme activation assays including Malaria Box compounds for P. falciparum CaM

   PMID:32821880

   Open questions at the time

   • Selectivity window over human CaM is narrow (within threefold)
   • Cellular efficacy of inhibitors against endogenous PfCaM not shown
9. 2023 High

   Structural analysis explained how PfCaM recognizes targets, showing multiple non-classical binding modes at its hydrophobic pockets that achieve nanomolar affinity via co-existing conformers.

   Evidence X-ray crystallography of Ca2+-saturated PfCaM-melittin complex with molecular dynamics simulations

   PMID:36906144

   Open questions at the time

   • Non-classical modes shown with melittin, not with physiological parasite targets
   • Functional consequence of multi-mode binding not tested
10. 2024 Medium

    Additional Ca2+-signaling connectivity was extended by demonstrating that PfCaM physically interacts with the essential ring-stage phosphatase PP7.

    Evidence conditional PP7 disruption with phosphoproteomics and co-immunoprecipitation identifying the calmodulin interaction in P. falciparum

    PMID:39387582

    Open questions at the time

    • Functional significance of the CaM-PP7 interaction for PfCaM not established
    • Interaction interface not mapped
11. 2026 Low

    In vitro binding surveys placed PfCaM as a candidate light chain for parasite myosins, binding the MyoB IQ2 motif and up to six sites in the MyoF neck.

    Evidence recombinant binding assays, small-angle X-ray scattering, structural prediction and pull-downs for MyoB and MyoF in P. falciparum

    PMID:36273584 PMID:42141018

    Open questions at the time

    • Binding shown in vitro without functional validation for PfCaM specifically
    • PfCaM is one of several candidate light chains, so physiological role at these myosins is uncertain

• How PfCaM selects among its many effectors (PfPKB, calcineurin, PP7, candidate myosins) in space and time during the intraerythrocytic cycle, and whether it is genetically essential, remains unresolved.
• No conditional knockout of PF3D7_1418300 itself reported
• Effector selection and stage-specific partitioning of Ca2+ signals unmapped